« Back
Home /
SGI-1776 free base

SGI-1776 free base

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	100mg
Item no.	TMO-T3078-100mg
CASRN	1025065-69-3
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	SGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.
Shipping	cool pack
Storage	-20°
Target names or alias	SGI-1776 free base , Pim-Kinase Inhibitor IX
Molecular Weight	405, 42
Pathway	Angiogenesis\|\|\|Autophagy\|\|\|Chromatin/Epigenetic\|\|\|Apoptosis\|\|\|JAK/STAT signaling\|\|\|Tyrosine Kinase/Adaptors
Target	Autophagy\|\|\|Apoptosis\|\|\|Pim\|\|\|FLT

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100mg

available

Delivery expected until 6/6/2024